Come visit our new corporate website showcasing the full breadth of our robust IP/product portfolio. creativemedicaltechnology.com $CELZ @caverstem FemCelz #OTC #stocks #investing #biotechnology #trading #seekingalpha #NYSE #motleyfool #regenerativemedicine

We're actively engaged in expanding our provider network to find and integrate clinics that are great fits for multiple CELZ patented procedures. #OTC #stocks #investing #biotechnology #trading #seekingalpha #menshealth #WomensHealth #NYSE #motleyfool $CELZ CaverStem FemCelz

"Using cells as drugs represents a more viable alternative to existing approaches because the stem cells not only reduce inflammation, but also have ability to induce healing of injured tissue." - Dr. Ichim, CELZ CSO #biotechnology #neurology #oncology #motleyfool $CELZ

As we emerge from our initial stages of commercialization we are streamlining our communication and web based platforms to improve information sharing with our patients, providers, and shareholders. #OTC #stocks #biotechnology #seekingalpha #motleyfool $CELZ CaverStem FemCelz

We've been working not only on expanding the reach of our patented CaverStem® procedure, but we've also been (and will continue to be) vigilant in protecting our IP against various forms of infringement. #OTC #investing #Biotechnology #seekingalpha #NYSE #motleyfool $CELZ

We are pleased to announce the completion of the data analysis and submission of a research paper describing a total of 140 patients treated with the CaverStem® procedure. prnewswire.com/news-releases/… #OTC #investing #biotechnology #trading #seekingalpha #NYSE #motleyfool $CELZ

"In the submitted paper, a total of 40 patients were treated in the primary trial and 100 in the clinical registry. This signifies one of the largest clinical studies of a non-drug treatment for erectile dysfunction." prnewswire.com/news-releases/… #OTC #investing #biotechnology $CELZ

CELZ Board of Directors Member, Dr. Amit Patel, discussing the significance of the completion of the CaverStem® clinical trial report when looking at the progression from initial research in 2013 through its' first phase of commercialization. #OTC #stocks #biotechnology $CELZ

As noted in our PR this week, our CaverStem® clinical trial information has been updated to reflect the addition of the 100 patient clinical registry. clinicaltrials.gov/ct2/show/NCT03… #OTC #stocks #investing #biotechnology #trading #seekingalpha #NYSE #motleyfool $CELZ

Sexual function and cardiovascular disease: what the general cardiologist needs to know. heart.bmj.com/content/105/2/… @mbmd17 Institute for Advanced Urology Dr Amit Patel Peter Niemczyk antoniniurology Elite Health Hawaii Victor Liu M.D. Creative Medical Technology Holdings, Inc. CaverStem

We are very excited to announce our partnership with EDGE Media Network! Be on the lookout for our CaverStem contest that begins October 1, with a grand prize of an all-inclusive trip to Elite Health Hawaii in #Honolulu for a free CaverStem® procedure. finance.yahoo.com/news/creative-… $CELZ

New article on EDGE Media Network talking about CaverStem being a medical breakthrough for the treatment of erectile dysfunction. edgemedianetwork.com/health_fitness… #ThursdayMotivation #menshealth #ED #Biotechnology #lgbtq #gay #health #stemcells

CaverStem® is a long lasting and all natural alternative to current treatments for erectile dysfunction. Find out more about our patented procedure at caverstem.com #health #ED #sexualhealth #impotence #sex #MensHealth #regenerativemedicine #WednesdayWisdom

"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the forefront as we close out the year." prnewswire.com/news-releases/… #health #biotechnology #womenshealth #stocks #investing #OTC $CELZ CaverStem FemCelz

Creative Medical Technology Holdings, Inc. Discusses CaverStem and Other Patented Technology with The Stock Day Podcast Full Story: bit.ly/2VQebtX Stock Day Media Podcast $CELZ #OTC #OTCMarkets #OTCStocks #CELZ #CEO #stockDayPodcast #Technology #stockdaymedia #Patent